Enterin

Philly Biotech Enterin Inc. Gets FDA Nod for Investigational New Drug Application to Treat Patient with MSA

PHILADELPHIA, PA — Enterin Inc., a privately held, Philadelphia-based, clinical-stage biopharmaceutical company, recently announced the acceptance by the U.S. Food and Drug Administration (FDA) of an investigator-sponsored Investigational New Drug (IND) …

Philly Biotech Enterin Inc. Gets FDA Nod for Investigational New Drug Application to Treat Patient with MSA Read More